Precision Health Clinical Trials

Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging

Condition:   Non Small Cell Lung Cancer
Intervention:   Procedure: Liquid biopsy
Sponsors:   OncoRadiomics;   University Hospital, Antwerp
Not yet recruiting

Biological Underpinnings of Socio-emotional Regulation in Preterm Infants and Healthy Controls

Conditions:   Preterm Birth;   Parent-Child Relations;   Epigenetics
Interventions:   Diagnostic Test: DNA methylation of target genes;   Diagnostic Test: EEG acquisition
Sponsor:   IRCCS Eugenio Medea

Danish Elder Lymphoma Patient Hematopoietic Investigation

Conditions:   Lymphoma;   Chemotherapy-induced Neutropenia;   Chemotherapy-Related Leukemia;   Chemotherapeutic Toxicity
Intervention:   Diagnostic Test: DNA repair gene mutation analysis
Sponsors:   Rigshospitalet, Denmark;   Tarec C. El-Galaly, Aaalborg University Hospital, Aalborg, Denmark;   Thomas Stauffer Larsen, Odense University Hospital, Odense, Denmark;   Judit M. Jørgensen, Aarhus University Hospital, Aarhus, Denmark;   Troels Møller Thomsen, Gødstrup Regional Hospital, Gødstrup, Denmark;   Michael Thorsgaard, Vejle University Hospital, Vejle, Denmark;   Andriette Dessau-Arp, Southern Jutland University Hospital, Esbjerg, Denmark;   Jacek A. Kisielewicz, Sønderborg Regional Hospital, Sønderborg, Denmark;   Kathrine Grell, Danish Cancer Society, Copenhagen, Denmark;   Lars Møller Pedersen, Zealand University Hospital, Roskilde, Denmark;   Peter Brown, Rigshospitalet, Copenhagen, Denmark;   Kirsten Grønbæk, Rigshospitalet, Copenhagen, Denmark;   Jack Cowland, Rigshospitalet, Copenhagen, Denmark;   Mette Klarskov Andersen, Rigshospitalet, Copenhagen, Denmark

Tempus NSCLC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With NSCLC Using NGS Assays

Condition:   Non-Small Cell Lung Cancer
Intervention:   Other: Observation
Sponsor:   Tempus Labs

Cellular-Mediated Immunity in COVID-19

Conditions:   Covid19;   Thromboembolism
Interventions:   Diagnostic Test: Multitest 6 color TBNK and BD Lyotubes;   Biological: genomicDNA extraction
Sponsor:   University of Campania "Luigi Vanvitelli"

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Condition:   Colorectal Cancer
Intervention:   Other: Observation
Sponsor:   Tempus Labs

GWAS in NMDAR Encephalitis

Condition:   Autoimmune Encephalitis
Intervention:   Genetic: GWAS
Sponsor:   Hospices Civils de Lyon

Genomics of Fibrin Clot Structure in Patients With Constitutional Dysfibrinogenemia

Condition:   Hereditary Dysfibrinogenemia
Intervention:   Biological: Blood test
Sponsor:   University Hospital, Clermont-Ferrand

Clinical Performance Evaluation of the C2i-Test

Condition:   Muscle-Invasive Bladder Carcinoma
Intervention:   Diagnostic Test: C2i Test
Sponsors:   C2i Genomics;   New Jersey Urology;   University of Texas;   Baylor College of Medicine;   NY Health d/b/a New York Cancer and Blood Specialists;   The Cleveland Clinic;   Fox Chase Cancer Center;   New York University;   University of Washington;   Oregon Health and Science University;   University of Southern California;   Ohio State University

The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia

Conditions:   Sickle Cell Disease;   Kidney Diseases, Chronic
Intervention:   Other: Biospecimen/DNA collection and analysis
Sponsors:   University of Tennessee;   National Heart, Lung, and Blood Institute (NHLBI);   University of Illinois at Chicago;   University of Memphis;   University of North Carolina, Charlotte;   Wake Forest University;   University of North Carolina, Chapel Hill